Ezra Receives FDA Clearance for Enhanced AI-Powered MRI Technology

What You Should Know: 

– Ezra, a innovator in AI-driven cancer screening, today announced that its advanced Ezra Flash AI model has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). 

– The FDA clearance expands the capabilities of its AI-powered platform to provide faster, more affordable, and higher-quality full-body MRI scans.

Ezra Flash AI for MRI Image Quality

Ezra Flash, a Class II medical device, now enhances image quality for neuro, abdomen, and pelvis MRI scans, making it applicable across the entire body. This advancement allows Ezra to accelerate scan times and improve diagnostic accuracy, bringing the company closer to its goal of offering a 15-minute, $500 full-body MRI scan in 2026.

Ezra’s technology is currently available at 74 locations across 29 cities in the U.S. 

“This FDA clearance marks another milestone in our journey towards

 making affordable and fast full-body MRIs a reality,” said Emi Gal, founder and CEO of Ezra. “Our goal is to launch a 15-minute, $500 full body MRI scan in 2026, and this new FDA clearance is an important step in that direction.”